NM_024513.4:c.3587+15C>T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_024513.4(FYCO1):​c.3587+15C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.113 in 1,613,428 control chromosomes in the GnomAD database, including 14,042 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.089 ( 1011 hom., cov: 33)
Exomes 𝑓: 0.12 ( 13031 hom. )

Consequence

FYCO1
NM_024513.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.800

Publications

12 publications found
Variant links:
Genes affected
FYCO1 (HGNC:14673): (FYVE and coiled-coil domain autophagy adaptor 1) The gene encodes a Rab7 adapter protein that is implicated in the microtubule transport of autophagosomes. The encoded protein contains a RUN domain, a FYVE-type zinc finger domain, and Golgi dynamics (GOLD) domain. The encoded protein plays a role in microtubule plus end-directed transport of autophagic vesicles through interactions with the small GTPase Rab7, phosphatidylinositol-3-phosphate (PI3P), the autophagosome marker LC3, and the kinesin KIF5. Mutations in this gene are associated with inclusion body myositis (IBM) and autosomal recessive congenital cataracts (CATC2). [provided by RefSeq, Aug 2020]
FYCO1 Gene-Disease associations (from GenCC):
  • cataract 18
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • early-onset nuclear cataract
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • total early-onset cataract
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BP6
Variant 3-45959378-G-A is Benign according to our data. Variant chr3-45959378-G-A is described in ClinVar as Benign. ClinVar VariationId is 261732.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.337 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FYCO1NM_024513.4 linkc.3587+15C>T intron_variant Intron 12 of 17 ENST00000296137.7 NP_078789.2 Q9BQS8-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FYCO1ENST00000296137.7 linkc.3587+15C>T intron_variant Intron 12 of 17 1 NM_024513.4 ENSP00000296137.2 Q9BQS8-1

Frequencies

GnomAD3 genomes
AF:
0.0891
AC:
13559
AN:
152098
Hom.:
1013
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0178
Gnomad AMI
AF:
0.230
Gnomad AMR
AF:
0.0664
Gnomad ASJ
AF:
0.182
Gnomad EAS
AF:
0.00328
Gnomad SAS
AF:
0.350
Gnomad FIN
AF:
0.145
Gnomad MID
AF:
0.174
Gnomad NFE
AF:
0.110
Gnomad OTH
AF:
0.0919
GnomAD2 exomes
AF:
0.126
AC:
31461
AN:
249376
AF XY:
0.141
show subpopulations
Gnomad AFR exome
AF:
0.0166
Gnomad AMR exome
AF:
0.0641
Gnomad ASJ exome
AF:
0.188
Gnomad EAS exome
AF:
0.00256
Gnomad FIN exome
AF:
0.146
Gnomad NFE exome
AF:
0.112
Gnomad OTH exome
AF:
0.125
GnomAD4 exome
AF:
0.116
AC:
169272
AN:
1461212
Hom.:
13031
Cov.:
33
AF XY:
0.124
AC XY:
90334
AN XY:
726884
show subpopulations
African (AFR)
AF:
0.0160
AC:
534
AN:
33470
American (AMR)
AF:
0.0655
AC:
2929
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.180
AC:
4717
AN:
26134
East Asian (EAS)
AF:
0.00204
AC:
81
AN:
39700
South Asian (SAS)
AF:
0.343
AC:
29563
AN:
86250
European-Finnish (FIN)
AF:
0.144
AC:
7620
AN:
52986
Middle Eastern (MID)
AF:
0.189
AC:
1090
AN:
5766
European-Non Finnish (NFE)
AF:
0.104
AC:
115616
AN:
1111814
Other (OTH)
AF:
0.118
AC:
7122
AN:
60370
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
8120
16240
24361
32481
40601
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4154
8308
12462
16616
20770
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0890
AC:
13550
AN:
152216
Hom.:
1011
Cov.:
33
AF XY:
0.0950
AC XY:
7069
AN XY:
74420
show subpopulations
African (AFR)
AF:
0.0177
AC:
736
AN:
41546
American (AMR)
AF:
0.0662
AC:
1013
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.182
AC:
632
AN:
3472
East Asian (EAS)
AF:
0.00329
AC:
17
AN:
5164
South Asian (SAS)
AF:
0.350
AC:
1692
AN:
4828
European-Finnish (FIN)
AF:
0.145
AC:
1539
AN:
10588
Middle Eastern (MID)
AF:
0.167
AC:
49
AN:
294
European-Non Finnish (NFE)
AF:
0.110
AC:
7466
AN:
68000
Other (OTH)
AF:
0.0928
AC:
196
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
613
1226
1839
2452
3065
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
176
352
528
704
880
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.121
Hom.:
824
Bravo
AF:
0.0722
Asia WGS
AF:
0.172
AC:
599
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Cataract 18 Benign:3
Jan 22, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Aug 03, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.96
CADD
Benign
0.18
DANN
Benign
0.40
PhyloP100
-0.80
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs13069079; hg19: chr3-46000870; API